Q3 2019 results

Amsterdam, October 27, 2019

Philips delivers Q3 sales of EUR 4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of 12.4%

  • Sales in the quarter amounted to EUR 4.7 billion, with 6% comparable sales growth
  • Comparable order intake was in line with Q3 2018
  • Income from continuing operations amounted to EUR 211 million, including a charge of EUR 78 million related to a goodwill impairment, compared to EUR 307 million in Q3 2018
  • Adjusted EBITA margin was 12.4% of sales, compared to 13.2% of sales in Q3 2018
  • Income from operations amounted to EUR 320 million, compared to EUR 451 million in Q3 2018
  • EPS from continuing operations (diluted) amounted to EUR 0.23; Adjusted EPS from continuing operations (diluted) increased 10% compared to Q3 2018 to EUR 0.46
  • Operating cash flow increased to EUR 356 million, compared to EUR 265 million in Q3 2018; free cash flow increased to EUR 126 million, compared to EUR 52 million in Q3 2018
  • Lives Improved in underserved healthcare communities increased by 9 million compared to Q3 2018, mainly driven by our Personal Health businesses and Diagnosis & Treatment businesses.
  • Philips has once again been recognized as one of the top companies for sustainability performance in the global 2019 Dow Jones Sustainability Indices (DJSI) list. Philips scored 82 out of 100 points in the DJSI Health Care Equipment & Services industry group, further improving on its 2018 score to achieve the #2 ranking in 2019.
  • Philips topped the inaugural Fortune Sustainability All Stars list, in front of companies such as IBM, Intel, Walmart and Apple. The list recognizes companies based on their environmental innovation, resource use, and efforts to limit emissions.
  • Philips has teamed up with non-profit organization PURE (Point-of-care Ultrasound in Resource-limited Environments), on a pioneering tele-ultrasound program linking specialists around the globe with physicians in Rwanda.
  • With half the world’s population still lacking access to essential health service, Philips announced its participation in several activities aimed at driving Universal Health Coverage (UHC) during the 74th United Nations General Assembly (UNGA 74) week in New York.
Philips Image-Guided Therapy

Reinforcing leadership in image-guided therapy

Reinforcing its global leadership in image-guided therapy, Philips launched its highly successful Azurion platform in China, following clearance from the National Medical Products Administration. Moreover, in the US, Philips launched the longer 150 mm and 200 mm versions of its Stellarex low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients.

Read more
Philips Lumify ultrasound

Mobile ultrasound success

Philips’ app-based, mobile Lumify ultrasound solution delivered double-digit comparable sales and order intake growth, as it continues to set the industry standard by consistently delivering what customers need to provide the best care for their patients at the point of care – diagnostic clarity, reliability and continuous scanning, with a lightweight, replaceable transducer.

Read more
Philips Incisive CT platform

Innovative new CT platform

Philips introduced an industry-first ‘Tube for Life’ guarantee on its new Incisive CT imaging platform in North America following its successful introduction in Europe and Asia. The new CT platform integrates innovations in imaging, workflow, and lifecycle management, helping healthcare providers with smart clinical decision-making, increased efficiency and improved experience for patients and staff.

Read more
Philips Enterprise Diagnostic Informatics

Informatics acquisition completed

Philips further expanded its Enterprise Diagnostic Informatics portfolio with the completion of the acquisition of Carestream Health’s Healthcare Information Systems business. Adding a state-of-the-art cloud-based imaging data platform, Philips’ offering now includes advanced Vendor Neutral Archive solutions, diagnostic and enterprise viewers, interactive multimedia reporting, AI-enabled clinical, operational and business analytics tools, as well as tele-radiology and diagnostic patient management services.

Read more
Philips IntelliVue bedside patientmonitor platform

Advances in patient monitoring

Reinforcing its leadership in patient monitoring solutions, Philips introduced the next-generation IntelliVue MX750 and MX850 bedside patient monitor platforms in Europe. These feature an extensive range of measurements and analytics, as well as new cybersecurity capabilities. Moreover, Philips signed multi-year enterprise patient monitoring agreements with the Kantonsspital Frauenfeld (Switzerland) and the University Clinic of Bonn (Germany) to improve workflow and clinical outcomes in these hospitals.

Read more
Philips SmartSleep Analyzer

Partnering on sleep care

Philips teamed up with Walgreens, one of the largest drugstore chains in the US, to integrate the clinically validated Philips SmartSleep Analyzer with the Walgreens Find Care platform, which helps connect Walgreens’ millions of mobile and online visitors to healthcare services. Walgreens Find Care users are now able to use Philips’ tool to help identify the potential reasons contributing to their sleep issues and connect to sleep diagnostics, guidance, products and solutions.

Read more
Philips connected power toothbrush

Global roll-out for connected toothbrush

Further broadening its product range in oral care, Philips has rolled out its connected Philips Sonicare ExpertClean globally. The new smart power toothbrush delivers superior oral care results with its sonic technology and deep clean brushing mode.


Make sure you receive the latest news from Philips and alerts for upcoming investor events by subscribing via the following link: Receive updates from Philips